Amgen Q2 Earnings Highlights Revenue: $9.18B (vs. est. $8.91B) Adjusted EPS: $6.02 (vs. est. $5.26) Adjusted Operating Income: $4.29B (vs. est. $3.95B) Outlook Full-Year Revenue Guidance: Raised to $35B–$36B (from prior $34.3B–$35.7B) Full-Year Adjusted EPS Guidance: Raised to $20.20–$21.30 (from prior $20–$21.20)
10,66K